{"id":3071,"date":"2022-03-02T09:30:38","date_gmt":"2022-03-02T08:30:38","guid":{"rendered":"https:\/\/www.direnzo.biz\/it\/?p=3071"},"modified":"2022-03-02T09:30:41","modified_gmt":"2022-03-02T08:30:41","slug":"eudragmdp-integration","status":"publish","type":"post","link":"https:\/\/www.direnzo.biz\/it\/eudragmdp-integration\/","title":{"rendered":"Organisation Management Services (OMS) &#8211; EudraGMDP Integration. What to do, when it should be done and who should do."},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1000\" height=\"667\" sizes=\"(max-width: 1000px) 100vw, 1000px\" src=\"https:\/\/www.direnzo.biz\/it\/wp-content\/uploads\/2022\/03\/integrazione-database-eudragmdp.jpg\" alt=\"\" class=\"wp-image-3069\" srcset=\"https:\/\/www.direnzo.biz\/it\/wp-content\/uploads\/2022\/03\/integrazione-database-eudragmdp.jpg 1000w, https:\/\/www.direnzo.biz\/it\/wp-content\/uploads\/2022\/03\/integrazione-database-eudragmdp-300x200.jpg 300w, https:\/\/www.direnzo.biz\/it\/wp-content\/uploads\/2022\/03\/integrazione-database-eudragmdp-768x512.jpg 768w\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Following the publication of the <strong>regulation of veterinary medicines<\/strong> <a href=\"https:\/\/www.salute.gov.it\/portale\/medicinaliVeterinari\/dettaglioContenutiMedicinaliVeterinari.jsp?lingua=italiano&amp;id=5605&amp;area=veterinari&amp;menu=regolamento#:~:text=Stabilisce%20norme%20per%20la%20vendita,veterinari%20e%20aumentarne%20la%20disponibilit%C3%A0\" target=\"_blank\" rel=\"noreferrer noopener\">(EU) 2019\/6<\/a>, EMA has decided to implement the information regarding veterinary medicines in the <strong>EudraGMDP database<\/strong>. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In particular, the development of the modules \u201c<em>Manufacturing and Importation Authorisation<\/em>\u201d (MIA) and \u201c<em>Registration of Active Substance manufacturers, Importers and Distributors<\/em>\u201d (API-Reg) has already been concluded while it is still ongoing for \u201c<em>Wholesale Distribution Authorisation<\/em>\u201d (WDA). The changes in the GDP module will be implemented in the first 4 months of 2022.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, the inclusion of <strong>veterinary companies<\/strong> and products is not the only novelty for the database.; in fact, in the last few months the project about the integration with the portal <a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/data-medicines-iso-idmp-standards\/spor-master-data\/organisation-management-service-oms\" target=\"_blank\" rel=\"noreferrer noopener\">Organisation Management Services<\/a> (OMS) is being completed, to obtain a standardised system on the <strong>stakeholders<\/strong> data for all countries, than can be used in regulatory processes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In details, the OMS dictionary, active as of 2017, is a database providing a list of organisations including their location address, to be used as reference and support for community regulatory activities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The benefits of the use of this database primarily include the <strong>standardisation of the reported<\/strong> information and the attribution of an identification code for the organisation and their locations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">EMA has considered that these features could be exploited for regulatory purposes and integrated with the EudraGMDP system; in fact, while so far the agencies are responsible for the data upload into EudraGMDP, in the next future, the data present into EudraGMDP will be extrapolated directly from the OMS database thus limiting \u2013 in fact \u2013 any misalignment and errors between the various Competent Authorities involved.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A dedicated team at EMA is working on the flow of all the data currently reported into the EudraGMDP portal and to delete any duplicates; so far, the data of 7,000 manufacturers and more than 12,000 holders have already been processed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">All companies (including manufacturers, <strong>EU and extra-EU importers<\/strong> and <strong>distributors of human and veterinary medicinal<\/strong> products and active substances) will be directly responsible for the control of the information reported into OMS and, if the data reported are not correct, they shall request an amendment; this, however, shall occur as of 28 January 2022, in order to prevent any risk of hindering this first cleansing process, currently ongoing.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Therefore, as of <strong>28 January 2022<\/strong>, before requesting a new\/updated manufacturing or distribution authorisation to the national competent authorities, companies shall verify whether their data are correctly <strong>registered into OMS<\/strong>. If not, a request of amendment shall be submitted.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This procedure becomes essential in order to have in the future a correct transcription on <strong>EudraGMDP<\/strong>; this responsibility is assigned to manufacturers even if anyone (<a href=\"\/it\/?p=2661\">MA holders<\/a>, manufacturers and even the national agencies) can submit a request of amendment via a \u201c<strong>change request<\/strong>\u201d, in the case of erroneous data.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To raise a change request it is necessary to have a <strong>SPOR account<\/strong> and submit valid supporting documents. We are available for any further clarification.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Written by: Chiara Tatangelo \u2013 Barbara Altieri \u2013 Valeria Cardinale \u2013 Giorgia Martini<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Foto by:\u00a0<a href=\"https:\/\/pixabay.com\/it\/illustrations\/nuvola-conservazione-3843352\/\" target=\"_blank\" rel=\"noreferrer noopener\">geralt<\/a>\u00a0da Pixabay<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Following the publication of the regulation of veterinary medicines (EU) 2019\/6, EMA has decided to implement the information regarding veterinary medicines in the EudraGMDP database. In particular, the development of the modules \u201cManufacturing and Importation Authorisation\u201d (MIA) and \u201cRegistration of Active Substance manufacturers, Importers and Distributors\u201d (API-Reg) has already been concluded while it is still<br \/><a class=\"moretag\" href=\"https:\/\/www.direnzo.biz\/it\/eudragmdp-integration\/\">+ Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":3072,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-3071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/posts\/3071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/comments?post=3071"}],"version-history":[{"count":0,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/posts\/3071\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/media\/3072"}],"wp:attachment":[{"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/media?parent=3071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/categories?post=3071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.direnzo.biz\/it\/wp-json\/wp\/v2\/tags?post=3071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}